Pharmacologic Treatment of Sex Offenders With Paraphilic Disorder

  title={Pharmacologic Treatment of Sex Offenders With Paraphilic Disorder},
  author={Frederico D Garcia and H{\'e}lo{\"i}se Delavenne and Alessandra Almeida Assumpç{\~a}o and Florence Thibaut},
  journal={Current Psychiatry Reports},
Sexual offending is both a social and a public health issue. Evidence demonstrates that a combination of pharmacological and psychotherapeutic approaches may reduce or even eliminate deviant sexual behavior in sex offenders with paraphilic disorders. In this article, we will review pharmacological treatment options for sex offenders with paraphilias. Both serotonin selective reuptake inhibitors (SSRIs) and antiandrogen treatments have been used with reported success in decreasing recidivism… 
Pharmacological treatment of paraphilias.
  • F. Thibaut
  • Psychology, Medicine
    The Israel journal of psychiatry and related sciences
  • 2012
Antiandrogens, and mostly GnRH analogues, significantly reduce the intensity and frequency of deviant sexual arousal and behavior, although informed consent is necessary in all cases.
Treatment of Paraphilic Sex Offenders
Paraphilic disorders are characterized by recurrent, intense, sexually arousing fantasies, urges, or behaviors, over a period ≥6 months, generally involving nonhuman objects, suffering, or
Pharmacotherapy for Sexual Offenders
This chapter addresses the barriers to pharmacologic management, state of the art of patient selection, and use of antiandrogen and other psychiatric drugs in this population of sex offenders.
Pharmacologic treatment of paraphilias.
The Biological Treatment of Paraphilic Disorders: an Updated Review
These guidelines offer clinicians potentially useful, rational approaches to assessing treatment need in individuals with paraphilic disorders and suggest neuroimaging research suggests that functional magnetic resonance imaging may offer further promise in effectively assessing paraphilic Disorders to help direct treatment options.
The pharmacologic treatment of problematic sexual interests, paraphilic disorders, and sexual preoccupation in adult men who have committed a sexual offence
All participants agreed that continuing international collaboration would be very useful for the development of ethical international prescribing guidelines, as well as pooling data from studies on the efficacy and utility of pharmacological and other biological treatments for people who have committed sexual offences.
Treatment of Paraphilic Disorders
Management and treatment options in both non-coercive and coercive paraphilic patients are described, with emphasis on the two diagnostic categories about which there has been the most research and writing: transvestic fetishism and pedophilia.
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders
An algorithm is proposed for the treatment of paraphilic disorders in adolescent sexual offenders or those who are at risk, and the main purposes are to improve the quality of care and to aid physicians in their clinical decisions.
Gonadotrophin-releasing hormone agonist treatment for sexual offenders: A systematic review
It is recommended that future research must be performed before the effectiveness and tolerability of gonadotrophin-releasing hormone agonists in this population can be confirmed.
The efficacy, safety and ethics of the use of testosterone-suppressing agents in the management of sex offending
The use of medication to manage the risk of sex offending in males is appropriate under the right circumstances and a Medical Ethics framework upon which to facilitate decision-making is noted.


Differential Pharmacological Treatment of Paraphilias and Sex Offenders
An algorithm for differential pharmacotherapy of paraphilias is developed and a protocol on side effects, contraindications, and monitoring of CPA and LHRH agonists is presented.
Current Concepts in the Pharmacotherapy of Paraphilias
This review of the literature provides suggestive evidence that paraphilias are well characterized disorders marked by pathological dimensions and available data on the use of selective serotonin reuptake inhibitors, steroidal antiandrogens and GnRH analogues strongly suggest the efficacy of these treatments for paraphilic disorders.
The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour.
  • J. Bradford
  • Psychology, Medicine
    Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 2001
Various pharmacological agents including serotonin reuptake inhibitors, antiandrogens, LHRH agonists, and others have been documented as reducing sexual desire and an algorithm for the use of these drugs in the treatment of the paraphilias as well nonparaphilic hypersexuality is outlined.
Pharmacology of sexually compulsive behavior.
  • V. Codispoti
  • Psychology
    The Psychiatric clinics of North America
  • 2008
Does sexual offender treatment work? A systematic review of outcome evaluations.
A systematic review of controlled outcome evaluations of psychosocial and organic sexual offender treatment found findings are promising but more differentiated evaluations of high quality are needed.
Physical and Chemical Castration of Sex Offenders: A Review.
ABSTRACT Castration, or removal of the testes, has been documented throughout history, occurring for a variety of social, punishment, and medical reasons. Currently, both “physical” and “chemical”
Drug treatment of paraphilic and nonparaphilic sexual disorders.
  • D. Guay
  • Medicine, Biology
    Clinical therapeutics
  • 2009
The characteristics of persistent sexual offenders: a meta-analysis of recidivism studies.
A meta-analysis of 82 recidivist studies identified deviant sexual preferences and antisocial orientation as the major predictors of sexual recidivism for both adult and adolescent sexual offenders.